Integrative immunogenomic analysis of gastric cancer dictates novel immunological classification and the functional status of tumor‐infiltrating cells-Reference-Cited by-同舟云学术

Integrative immunogenomic analysis of gastric cancer dictates novel immunological classification and the functional status of tumor‐infiltrating cells

Published:2020-01 Issue:10 Volume:9 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin. Transl. Immunol.

Author:

Sato Yasuyoshi¹²³,Wada Ikuo⁴,Odaira Kosuke¹,Hosoi Akihiro¹,Kobayashi Yukari¹,Nagaoka Koji¹,Karasaki Takahiro¹,Matsushita Hirokazu¹⁵,Yagi Koichi²,Yamashita Hiroharu²,Fujita Masashi⁶,Watanabe Shuichi⁷⁸,Kamatani Takashi⁷⁹¹⁰,Miya Fuyuki⁷¹¹,Mineno Junichi¹²,Nakagawa Hidewaki⁶,Tsunoda Tatsuhiko⁷⁹¹¹,Takahashi Shunji³,Seto Yasuyuki²,Kakimi Kazuhiro¹¹³

Affiliation:

1. Department of Immunotherapeutics The University of Tokyo Hospital Tokyo Japan

2. Department of Gastrointestinal Surgery Graduate School of Medicine The University of Tokyo Tokyo Japan

3. Department of Medical Oncology The Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo Japan

4. Department of Surgery Tokyo Metropolitan Bokutoh Hospital Tokyo Japan

5. Division of Translational Oncoimmunology Aichi Cancer Center Research Institute Nagoya Aichi Japan

6. Laboratory for Cancer Genomics RIKEN Center for Integrative Medical Sciences Kanagawa Japan

7. Department of Medical Science Mathematics Medical Research Institute Tokyo Medical and Dental University Tokyo Japan

8. Department of Hepato‐Biliary‐Pancreatic Surgery Graduate School of Medicine Tokyo Medical and Dental University Tokyo Japan

9. Department of Biological Sciences Graduate School of Science The University of Tokyo Tokyo Japan

10. Division of Pulmonary Medicine Department of Medicine Keio University School of Medicine Tokyo Japan

11. Laboratory for Medical Science Mathematics RIKEN Center for Integrative Medical Sciences

12. Takara Bio Inc Shiga Japan

13. Cancer Immunology Data Multi‐level Integration Unit Medical Science Innovation Hub Program RIKEN Tokyo Japan

Funder

RIKEN

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1194

Reference54 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial

3. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial

4. Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing

5. Comprehensive molecular characterization of gastric adenocarcinoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of, and expectations for, lipid nanoparticle technology: From cellular targeting to organelle targeting;Journal of Controlled Release;2024-06

2. Tumor and Peritoneum-Associated Macrophage Gene Signature as a Novel Molecular Biomarker in Gastric Cancer;International Journal of Molecular Sciences;2024-04-08

3. Microsatellite instability: A 2024 update;Cancer Science;2024-03-25

4. Alterations in Intratumoral Immune Response before and during Early-On Nivolumab Treatment for Unresectable Advanced or Recurrent Gastric Cancer;International Journal of Molecular Sciences;2023-11-22

5. Personalized immune subtypes based on machine learning predict response to checkpoint blockade in gastric cancer;Briefings in Bioinformatics;2022-12-26